| Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic–Is an update of legal restrictions warranted? M Meyer, J Strasser, P Köck, M Walter, M Vogel, KM Dürsteler International Journal of Drug Policy 101, 103548, 2022 | 30 | 2022 |
| Co-occurring mental disorders in transitional aged youth with substance use disorders–a narrative review P Köck, M Meyer, J Elsner, KM Dürsteler, M Vogel, M Walter Frontiers in Psychiatry 13, 827658, 2022 | 12 | 2022 |
| «One prick and then it´ s done»: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment M Meyer, R Eichenberger, J Strasser, KM Dürsteler, M Vogel Harm Reduction Journal 18, 1-10, 2021 | 10 | 2021 |
| Besonderheiten in der therapeutischen Beziehung bei forensisch-psychiatrischen Patienten M Meyer, H Hachtel, M Graf Medizinische Fakultät der Universität Basel, 2020 | 10 | 2020 |
| Mental disorders in individuals with exercise addiction—a cross-sectional study M Meyer, I Sattler, H Schilling, UE Lang, A Schmidt, F Colledge, M Walter Frontiers in psychiatry 12, 751550, 2021 | 9 | 2021 |
| The upcoming synthetic ultrapotent opioid wave as a foreseeable disaster RM Krausz, JN Westenberg, M Meyer, F Choi The Lancet Psychiatry 9 (9), 699-700, 2022 | 8 | 2022 |
| Exploring why patients in heroin-assisted treatment are getting incarcerated—a qualitative study M Meyer, B Rist, J Strasser, UE Lang, M Vogel, KM Dürsteler, M Walter BMC psychiatry 22 (1), 169, 2022 | 7 | 2022 |
| Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study M Vogel, M Meyer, JN Westenberg, A Kormann, O Simon, ... Harm Reduction Journal 20 (1), 2, 2023 | 6 | 2023 |
| Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment M Meyer, JN Westenberg, J Strasser, KM Dürsteler, UE Lang, M Krausz, ... Harm Reduction Journal 19 (1), 63, 2022 | 6 | 2022 |
| Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland T Schwarz, J Anzenberger, M Busch, G Gmel, L Kraus, M Krausz, ... Drug and Alcohol Dependence 254, 111036, 2024 | 5 | 2024 |
| Exploring the potential and limitations of ChatGPT for academic peer-reviewed writing: Addressing linguistic injustice and ethical concerns AMY Tai, M Meyer, M Varidel, A Prodan, M Vogel, F Iorfino, RM Krausz Journal of Academic Language and Learning 17 (1), T16-T30, 2023 | 5 | 2023 |
| Shifting drug markets in North America-a global crisis in the making? M Meyer, JN Westenberg, KL Jang, F Choi, S Schreiter, N Mathew, C King, ... International journal of mental health systems 17 (1), 36, 2023 | 4 | 2023 |
| Effects of cannabis regulation in Switzerland: Study protocol of a randomized controlled trial L Baltes-Flueckiger, R Steinauer, M Meyer, M Vogel, M Walter Frontiers in psychiatry 14, 1139325, 2023 | 4 | 2023 |
| Sexual dysfunctions in patients receiving opioid agonist treatment and heroin-assisted treatment compared to patients in private practice—identifying group differences and … M Meyer, P Brunner, L Geissmann, M Gürtler, F Schwager, R Waldis, ... Frontiers in Psychiatry 13, 846834, 2022 | 4 | 2022 |
| A call for an evidence-based strategy against the overdose crisis RM Krausz, JN Westenberg, AMY Tai, H Fadakar, V Seethapathy, ... The Canadian Journal of Psychiatry 69 (1), 5-9, 2024 | 3 | 2024 |
| Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study M Meyer, F Gygli, JN Westenberg, O Schmid, J Strasser, UE Lang, ... Addiction Science & Clinical Practice 18 (1), 43, 2023 | 2 | 2023 |
| Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study JN Westenberg, M Meyer, J Strasser, M Krausz, KM Dürsteler, L Falcato, ... Addiction Science & Clinical Practice 18 (1), 15, 2023 | 2 | 2023 |
| Exercise Addiction–Status, Identification and Treatment F Colledge, M Meyer Praxis, 2022 | 2 | 2022 |
| Case report: CBD cigarettes for harm reduction and adjunctive therapy in a patient with schizophrenia and substance use disorder M Meyer, M Walter, S Borgwardt, A Scheidegger, E Lang, P Köck Frontiers in Psychiatry 12, 712110, 2021 | 2 | 2021 |
| Bewegungssucht und komorbide Störungen F Colledge, M Meyer Schw Z Psychiatr Neurol 3, 10-13, 2021 | 2 | 2021 |
